Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-11-08
2005-11-08
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S016700, C514S017400, C530S300000, C530S317000, C530S329000, C530S334000, C530S338000, C530S344000, C424S009100
Reexamination Certificate
active
06962902
ABSTRACT:
This invention relates generally to dipeptides and tripeptides and to methods for pharmaceutical treatment of mammals using analogs of such dipeptides and tripeptides. More specifically, the invention relates to tripeptides and their analogs, to pharmaceutical compositions containing such dipeptides and tripeptides and to methods of treatment of mammals using such dipeptides and tripeptides. In addition, the invention relates to methods of treatment of mammals using such dipeptides and tripeptides for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm.
REFERENCES:
patent: 3842067 (1974-10-01), Sarantakis
patent: 3862925 (1975-01-01), Sarantakis et al.
patent: 3972859 (1976-08-01), Fujino et al.
patent: 4105603 (1978-08-01), Vale, Jr. et al.
patent: 4244946 (1981-01-01), Rivier et al.
patent: 4297346 (1981-10-01), Rips et al.
patent: 4415558 (1983-11-01), Vale, Jr. et al.
patent: 4490364 (1984-12-01), Rivier et al.
patent: 4839343 (1989-06-01), Waeber et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 5270302 (1993-12-01), Shiosaki et al.
patent: 5328899 (1994-07-01), Boublik et al.
patent: 5410018 (1995-04-01), Spindel et al.
patent: 5993843 (1999-11-01), Sakurada et al.
patent: 6235718 (2001-05-01), Balasubramanium et al.
patent: 288965 (1988-04-01), None
patent: 0268297 (1988-05-01), None
patent: 0381340 (1990-08-01), None
patent: WO 9103494 (1991-03-01), None
Raymond et al. J. Med. Chem. 1992, 35, 3653-3659.
A. Balasubramaniam et al.,Characterization of Neuropeptide Y Binding Sites in Rat Cardiac Ventricular Membranes, Peptides, vol. 11, 1990, pp. 545-550.
A. Balasubramanium et al.,Synthesis and biological properties of 4-norleucine-neuropeptide Y; secondary structure of neuropeptide Y, Biochimica et Biophysica Acta, vol. 997, 1989, pp. 176-181.
Elizabeth N. Barnes et al.,The Fine Structure of Continuous Human Neuroblastoma Lines SK-N-SH, SK-N-BE(2),and SK-N-MC., In Vitro, vol. 17, No. 7, Jul. 1981, pp. 619-631.
Ulrich Bickel et al.,Synthesis and Bioactivity of Monobiotinylated DALDA: A Mu-Specific Oploid Peptide Designed for Targeted Brain Delivery, Journal of Pharmacology and Experimental Therapeutics, vol. 268, No. 2, 1994, pp. 791-796.
D. Bleakman et al.,Neuropeptide Y Inhibits Ca2 + influx into cultured dorsal root ganglion neurones of the rat via a Y2 receptor, Dept. of Pharmacological and Physiological Sciences, University of Chicago, Mar. 11, 1991, pp. 1781-1789.
W.T. Chance et al.,Pertussia Toxin Inhibits Neuropeptide Y-Induced Feeding in Rats, Peptides, vol. 10, 1989, pp. 1283-1286.
S.T. Cheung et al.,N-Methylamino acids in peptides synthesis. V. The synthesis of N-tert-butyloxycarbonyl, N-methylamino acids by N-methylation, Can. J. Chem., vol. 55, 1997, pp. 906-910.
William F. Colmers et al.,The Biology of Neuropeptide Y and Related Peptides, Humana Press Inc., 1993, pp. 197-239.
David H. Coy et al.,Solid Phase Reductive Alkylation Techniques in Analogue Peptide Bond and Side-Chain Modification, Tetrahedron, vol. 44, No. 3, 1988, pp. 835-841.
D. De Wied (Ed.),Neuropeptides, Basics and Perspectives, Elsevier Science Publishers, The Netherlands, 1990, Chap. V-IX.
Yvan Dumont et al.,Neuropeptide Y and Neuropeptide Y Receptor Subtypes in Brain and Peripheral Tissues, Progress in Neurobiology, vol. 38, 1992, pp. 125-167.
Jean-Alain Fehrentz et al.,An Efficient Synthesis of Optically Active a-(t-Butoxycarbonylamino)-aldehydes from a-Amino Acids, Communications, Aug. 1983, pp. 676-678.
James F. Flood et al.,Dissociation of the Effects of Neuropeptide Y on Feeding and Memory: Evidence for Pre-and Postsynaptic Mediation, Peptides, vol. 10, 1989, pp. 963-966.
Roger M. Freidinger et al.,Synthesis of 9-Fluorenylmethylozycarbonyl-Protected N-alkyl Amino Acids by Reduction of Oxazolidinones, J. Org. Chem., vol. 48, 1983, pp. 77-81.
Jannie Fuhlendorff et al.,[Leu31, Pro34] Neuropeptide Y: A specific Y1 receptor agonist, Biochemistry, Proc. Natl. Acad. Sci., vol. 87, Jan. 1990, pp. 182-186.
A.R. Gennaro et al. (Eds.),Remington's Phamaceutical Sciences, Mack Publishing Company, Easton, PA, 1990.
Glover et al.,Conformational studies on the pancreatic polypeptide hormone family, Eur. J. Biochem. vol. 142, 1985, pp. 379-385.
Eric A. Gordon et al.,Characterization of Functional Neuropeptide Y Receptors in a Human Neuroblastoma Cell Line, Journal of Neurochemistry, International Society for Neurochemistry, 1990, pp. 506-513.
E. Gross et al. (Eds.),The Peptides, vol. 1, Academic Press, Inc., New York, London, 1979, 26-52, 125-126, 156-174, 242-260, 293-304, 336-362.
E. Gross et al. (Eds.),The Peptides, vol. 3, Academic Press, Inc., New York, London, 1981, 1-99, 101-136, 203-252.
M. Heillig et al.,Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses, Acta Psychiatr. Scand., vol. 82, 1990, 95-114.
M. Heilig et al.,Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses, Dept. of Psychiatry and Neurochemistry, University of Lund, Lund, Sweden, Mar. 17, 1990, pp. 95-114.
Joseph Hinson et al.,Neuropeptide Y stimulates inositol phospholipid hydrolysis in rat brain miniprisms, Brain Research, vol. 446, 1988, pp. 379-382.
Jan M. Lundberg et al.,Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclick AMP formation and calcium antogonist inhibition of vasoconstriction, European Journal of Pharmacology, vol. 145, 1988, pp. 21-29.
R.B. Merrifield,Solid Phase Peptide Synthesis, I. The Synthesis of a Tetrapeptide, J. Am Chem. Soc.. Jul. 20, 1963, pp. 2149-2154.
Martin C. Michel,Receptors for neuropeptide Y: multiple subtypes and multiple second messengers, TiPS, vol. 12, Oct. 1991, pp. 389-394.
Shin-ichi Mihara et al.,Neuropeptide Y-induced intracellular Ca2+ increases in vascular smooth muscle cells, FEBS Letters, vol. 258, No. 1, Dec. 1989, pp. 79-82.
Harvey J. Motulsky et al.,Neuropeptide Y Mobilizes Ca2+and inhibits adenylate cyclase in human erythroleukemia cells, Amer. J. of Physiological Society, 1988, pp. E880-E885.
William M. Pardridge et al.,Endorphin Chimeric Peptides: Transport through the Blood-Brain Barrier in Vivo and Cleavage of Disulfide Linkage by Brain, Endocrinology, vol. 126, No. 2, 1990, pp. 977-984.
B. Penks et al.,New Synthetic Approach to Peptide Sulfated Esters, Synthesis and Biological Activities of CCK Analogs, Synthesis of Peptides: Methods, Inst. Med. Chem., Szeged, H-6720, Hung. Pept.: Struct. Funct. Proc. Am. Pept. Symp., 8th (1983) 119-122. (Editions: Hruby V.J.; Rich D.H) Piere Chem. Co.: Rockford, Ill.
G. Poste et al.,Lipid Vesicles as Carriers for Introducing Biologically Active Materials into Cells, Methods in Cell Biology, vol. XIV, Academic Press, New York, N.Y., 1976, 33-71.
Marc. Rodriguiz et al.,Synthesis and Biological Activities of Pseudopeptide analogues of the C-Terminal Heptapeptide fo Cholecystokinin, On the Importance of the Peptide Bonds, J. Med. Chem., vol. 30, 1987, pp. 1366-1373.
Y. Sasaki et al.,Solid Phase Synthesis of Peptides Containing the CH2NH Peptide Bond Isostere, Peptides, vol. 8, 1987, pp. 119-121.
Eberhard Schroder et al.,Methods of Peptide Synthesis, The Peptides, Academic Press, 1965, pp. 72-75.
Thue W. Schwartz et al.,Signal Epitopes in the Three-Dimensional Structure of Neuropeptide Y Interaction with Y1, Y2, and Pancreatic Polypeptide Receptors, Annals of New York Academy of Sciences, vol. 611, 1990, pp. 35-47.
Soren P. Sheikh et al.,Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas, American Physiological Society, 1991, pp. G250-G257.
Soren P. Sheikh et al.,Structural Characterization of Y1 and Y2 Receptors for Neuropeptide Y and Peptide YY by Affinity Cross-linking, J. Biol. Chem. vol. 265, No. 14, May 15, 1990, pp. 8304-8310.
Soren P. Sheikh et al.,Y2-type receptors for peptide YY on renal Proximal tubular cells in the rabbit, American Physiological Society, 1989, pp. F978-F984.
R.T. Shuman et al.,Structure-Activity Studies of Enkephalin Tetrapeptides, Pept.: Synth.
Balasubramanium Ambikaipakan
Chance William T.
Kam Chih-Min
University of Cincinnati
Weber Jon
Wood Herron & Evans L.L.P.
LandOfFree
Compounds for control of appetite, blood pressure,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for control of appetite, blood pressure,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for control of appetite, blood pressure,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3480738